It is consensus in the metabolomics community that standardized protocols should be followed for sample handling, storage and analysis, as it is of utmost importance to maintain constant measurement conditions to identify subtle biological differences. The aim of this work, therefore, was to systematically investigate the influence of freezing procedures and storage temperatures and their effect on NMR spectra as a potentially disturbing aspect for NMR-based metabolomics studies. Urine samples were collected from two healthy volunteers, centrifuged and divided into aliquots. Urine aliquots were frozen either at ？20 °C, on dry ice, at ？80 °C or in liquid nitrogen and then stored at ？20 °C, ？80 °C or in liquid nitrogen vapor phase for 1–5 weeks before NMR analysis. Results show spectral changes depending on the freezing procedure, with samples frozen on dry ice showing the largest deviations. The effect was found to be based on pH differences, which were caused by variations in CO 2 concentrations introduced by the freezing procedure. Thus, we recommend that urine samples should be frozen at ？20 °C and transferred to lower storage temperatures within one week and that freezing procedures should be part of the publication protocol.
References
[1]
Smolinska, A.; Blanchet, L.; Buydens, L.M.; Wijmenga, S.S. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal. Chim. Acta 2012, 750, 82–97, doi:10.1016/j.aca.2012.05.049.
[2]
Mannina, L.; Sobolev, A.P.; Capitani, D. Applications of NMR metabolomics to the study of foodstuffs: Truffle, kiwifruit, lettuce, and sea bass. Electrophoresis 2012, 33, 2290–2313, doi:10.1002/elps.201100668.
[3]
Martin, F.P.; Collino, S.; Rezzi, S. 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health. Magn. Reson. Chem. 2011, 49 (Suppl 1), S47–S54.
[4]
Foxall, P.J.; Price, R.G.; Jones, J.K.; Neild, G.H.; Thompson, F.D.; Nicholson, J.K. High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim. Biophys. Acta 1992, 1138, 305–314, doi:10.1016/0925-4439(92)90008-B.
[5]
Bernini, P.; Bertini, I.; Luchinat, C.; Nincheri, P.; Staderini, S.; Turano, P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J. Biomol. NMR 2011, 49, 231–243.
[6]
Assfalg, M.; Bertini, I.; Colangiuli, D.; Luchinat, C.; Schafer, H.; Schutz, B.; Spraul, M. Evidence of different metabolic phenotypes in humans. Proc. Natl. Acad. Sci. USA 2008, 105, 1420–1424.
[7]
Bernini, P.; Bertini, I.; Luchinat, C.; Nepi, S.; Saccenti, E.; Schafer, H.; Schutz, B.; Spraul, M.; Tenori, L. Individual human phenotypes in metabolic space and time. J. Proteome Res. 2009, 8, 4264–4271.
[8]
Lauridsen, M.; Hansen, S.H.; Jaroszewski, J.W.; Cornett, C. Human urine as test material in 1H NMR-based metabonomics: Recommendations for sample preparation and storage. Anal. Chem. 2007, 79, 1181–1186.
[9]
Bertram, H.C.; Malmendal, A.; Petersen, B.O.; Madsen, J.C.; Pedersen, H.; Nielsen, N.C.; Hoppe, C.; Molgaard, C.; Michaelsen, K.F.; Duus, J.O. Effect of magnetic field strength on NMR-based metabonomic human urine data. Comparative study of 250, 400, 500, and 800 MHz. Anal. Chem. 2007, 79, 7110–7115.
[10]
Maher, A.D.; Zirah, S.F.M.; Holmes, E.; Nicholson, J.K. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. Anal. Chem. 2007, 79, 5204–5211.
[11]
Saude, E.J.; Sykes, B.D. Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics 2007, 3, 19–27.
[12]
Barton, R.H.; Nicholson, J.K.; Elliott, P.; Holmes, E. High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: Validation study. Int. J. Epidemiol. 2008, 37 (Suppl 1), i31–i40.
[13]
Baryshnikova, O.K.; Williams, T.C.; Sykes, B.D. Internal pH indicators for biomolecular NMR. J. Biomol. NMR 2008, 41, 5–7.
[14]
Damm, U. Fortschritte in der Infrarot-Spektroskopie für die in vivo Blutglucoseanalytik. Ph.D. Thesis, Universit？t Duisburg-Essen, Essen, Germany, 2006.
[15]
Griffin, J.L.; Nicholls, A.W.; Daykin, C.A.; Heald, S.; Keun, H.C.; Schuppe-Koistinen, I.; Griffiths, J.R.; Cheng, L.L.; Rocca-Serra, P.; Rubtsov, D.V.; Robertson, D. Standard reporting requirements for biological samples in metabolomics experiments: mammalian/in vivo experiments. Metabolomics 2007, 3, 179–188.
[16]
Lenz, E.M.; Bright, J.; Wilson, I.D.; Hughes, A.; Morrisson, J.; Lindberg, H.; Lockton, A. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharmaceut. Biomed. Anal. 2004, 36, 841–849.
[17]
Fave, G.; Beckmann, M.; Lloyd, A.J.; Zhou, S.B.; Harold, G.; Lin, W.C.; Tailliart, K.; Xie, L.; Draper, J.; Mathers, J.C. Development and validation of a standardized protocol to monitor human dietary exposure by metabolite fingerprinting of urine samples. Metabolomics 2011, 7, 469–484.
[18]
Thompson, D.K.; Sloane, R.; Bain, J.R.; Stevens, R.D.; Newgard, C.B.; Pieper, C.F.; Kraus, V.B. Daily variation of serum acylcarnitines and amino acids. Metabolomics 2012, 8, 556–565.
